However, the use of noninvasive oxygen support, such as high-flow nasal cannula (HFNC) and noninvasive positive pressure ventilation (NIPPV), for the initial management of acute hypoxemic respiratory failure has increased during the COVID-19 pandemic due to the potential ventilator sparing effects.